Related references
Note: Only part of the references are listed.BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast
E. K. A. Millar et al.
BRITISH JOURNAL OF CANCER (2009)
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome
E. K. A. Millar et al.
ONCOGENE (2009)
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer
F. Andre et al.
ANNALS OF ONCOLOGY (2008)
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases
Argun Akcakanat et al.
CANCER (2008)
Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis
Nathalie Dourdin et al.
CANCER RESEARCH (2008)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype
David Voduc et al.
HUMAN PATHOLOGY (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
PTEN-deficient cancers depend on PIK3CB
Susan Wee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas
Enrique Lerma et al.
VIRCHOWS ARCHIV (2008)
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables
Woo Chul Noh et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Lao H. Saal et al.
NATURE GENETICS (2008)
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-IIIbreast cancer
Cornelia Liedtke et al.
BREAST CANCER RESEARCH (2008)
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
C. Ginestier et al.
ONCOGENE (2007)
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
Mattia Barbareschi et al.
CLINICAL CANCER RESEARCH (2007)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
Gizeh Perez-Tenorio et al.
CLINICAL CANCER RESEARCH (2007)
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti et al.
CANCER RESEARCH (2007)
Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women
Naomi Maruyama et al.
CLINICAL CANCER RESEARCH (2007)
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2007)
PIK3CA alterations in primary (de novo) and secondary glioblastomas
Daisuke Kita et al.
ACTA NEUROPATHOLOGICA (2007)
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer
E Tokunaga et al.
EUROPEAN JOURNAL OF CANCER (2006)
PIK3CA mutations in breast cancer are associated with poor outcome
SY Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer
V Jung et al.
MOLECULAR CANCER RESEARCH (2006)
PIK3CA mutation and histological type in breast carcinoma:: high frequency of mutations in lobular carcinoma
F Buttitta et al.
JOURNAL OF PATHOLOGY (2006)
The Akt pathway in human breast cancer: a tissue-array-based analysis
S Bose et al.
MODERN PATHOLOGY (2006)
Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients
E Tokunaga et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Oncogenic PI3K deregulates transcription and translation
AG Bader et al.
NATURE REVIEWS CANCER (2005)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard et al.
JOURNAL OF PATHOLOGY (2005)
Frequent mutation of the PIK3CA gene in ovarian and breast cancers
DA Levine et al.
CLINICAL CANCER RESEARCH (2005)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast
S Tsutsui et al.
ONCOLOGY (2005)
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
GJ Wu et al.
BREAST CANCER RESEARCH (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome
AR Panigrahi et al.
JOURNAL OF PATHOLOGY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens
P de Cremoux et al.
ENDOCRINE-RELATED CANCER (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer
PL Depowski et al.
MODERN PATHOLOGY (2001)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
